CN104529971B - 羟基甲基戊二酰辅酶a还原酶抑制剂 - Google Patents
羟基甲基戊二酰辅酶a还原酶抑制剂 Download PDFInfo
- Publication number
- CN104529971B CN104529971B CN201410843872.4A CN201410843872A CN104529971B CN 104529971 B CN104529971 B CN 104529971B CN 201410843872 A CN201410843872 A CN 201410843872A CN 104529971 B CN104529971 B CN 104529971B
- Authority
- CN
- China
- Prior art keywords
- acid
- compound
- compositionss
- saccharide
- hmg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
化合物 | 实施例1产物 | 实施例2产物 | 辛伐他汀 | 美伐他汀 | 普伐他汀 |
IC50(nM) | 0.05 | 0.1 | 4 | 2 | 8 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410843872.4A CN104529971B (zh) | 2014-01-30 | 2014-12-30 | 羟基甲基戊二酰辅酶a还原酶抑制剂 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410046605 | 2014-01-30 | ||
CN2014100466054 | 2014-01-30 | ||
CN201410843872.4A CN104529971B (zh) | 2014-01-30 | 2014-12-30 | 羟基甲基戊二酰辅酶a还原酶抑制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104529971A CN104529971A (zh) | 2015-04-22 |
CN104529971B true CN104529971B (zh) | 2017-01-25 |
Family
ID=52845643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410843872.4A Active CN104529971B (zh) | 2014-01-30 | 2014-12-30 | 羟基甲基戊二酰辅酶a还原酶抑制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104529971B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108558805A (zh) * | 2018-05-30 | 2018-09-21 | 日照市普达医药科技有限公司 | 一类血脂调节剂及其在防治心肌缺血中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6002021A (en) * | 1998-06-29 | 1999-12-14 | Industrial Technology Research Institute | Process for preparing 6(R)-{2-8'(S)-2",2"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one |
CN102245178A (zh) * | 2008-10-15 | 2011-11-16 | 神经元生物制药股份公司 | 莫纳可林j衍生物的生物合成 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444784A (en) * | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
-
2014
- 2014-12-30 CN CN201410843872.4A patent/CN104529971B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6002021A (en) * | 1998-06-29 | 1999-12-14 | Industrial Technology Research Institute | Process for preparing 6(R)-{2-8'(S)-2",2"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one |
CN102245178A (zh) * | 2008-10-15 | 2011-11-16 | 神经元生物制药股份公司 | 莫纳可林j衍生物的生物合成 |
Also Published As
Publication number | Publication date |
---|---|
CN104529971A (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7304091B2 (en) | Statin-like compounds | |
US5317031A (en) | Cholesterol lowering compounds | |
CN108918700A (zh) | 一种同时检测他汀侧链及其对映异构体杂质的方法 | |
CN104356118A (zh) | 多取代吡咯类他汀内酯脱水化合物及其用途 | |
Wu et al. | Phenolic metabolites from mangrove-associated Penicillium pinophilum fungus with lipid-lowering effects | |
JP2017105795A (ja) | ベニコウジカビ(monascus purpureus)から単離された化合物、その調製方法及び使用 | |
CN104529971B (zh) | 羟基甲基戊二酰辅酶a还原酶抑制剂 | |
Wu et al. | Four new cryptoporic acid derivatives from the fruiting bodies of Cryptoporus sinensis, and their inhibitory effects on nitric oxide production | |
TWI580689B (zh) | 甾醇類衍生物及其製備方法與應用 | |
CN104356119B (zh) | 多取代嘧啶类他汀内酯脱水化合物及其用途 | |
JPH0366676A (ja) | 3,5―ジヒドロキシペンタン酸誘導体、その製法およびそれを含有する抗高コレステロール血症剤 | |
CN107207404A (zh) | 化合物、其分离方法、合成方法及用途 | |
PT94584A (pt) | Processo para a preparacao de derivados de piranona ou de acido heptanoico | |
CN104356120B (zh) | 多取代喹啉类他汀内酯脱水化合物及其用途 | |
Choi et al. | Isolation and structural determination of squalene synthase inhibitor from Prunus mume fruit | |
KR100213896B1 (ko) | 인삼으로부터 아실-코에이:콜레스테롤 아실트랜스퍼라제(acat) 활성저해제의 제조방법 및 이를 함유하는 조성물 | |
CN104311517B (zh) | 他汀内酯脱水化合物及其用途 | |
CN103172693B (zh) | 一种甾醇类衍生物、其制备方法及用途 | |
CN105017231A (zh) | 多取代吲哚类他汀含氟修饰物及其用途 | |
TW201345920A (zh) | 一種甾醇類衍生物、其製備方法及用途 | |
CN104327057A (zh) | 多取代吲哚类他汀内酯脱水化合物及其用途 | |
CN105017230A (zh) | 多取代喹啉类他汀含氟衍生物及其用途 | |
Kim et al. | Cholesterol biosynthesis inhibitors of microbial origin | |
Syed | Statin in Prevention of Cardiac Diseases | |
CN105111173A (zh) | 多取代菲环类他汀含氟衍生物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: HMG-GoA reductase inhibitor Effective date of registration: 20170823 Granted publication date: 20170125 Pledgee: Huaxia Bank Beijing branch, Limited by Share Ltd Pledgor: BEIJING LABWORLD BIO-MEDICINE TECHNOLOGY CO., LTD. Registration number: 2017990000786 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181011 Granted publication date: 20170125 Pledgee: Huaxia Bank Beijing branch, Limited by Share Ltd Pledgor: BEIJING LABWORLD BIO-MEDICINE TECHNOLOGY CO., LTD. Registration number: 2017990000786 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20210629 Granted publication date: 20170125 |
|
PP01 | Preservation of patent right |